QFK
- Product code
- QFK
- Device name
- Tumor Gene Profiling Test
- Device class
- Class N
- Medical specialty
- Unknown
- Marketing pathway
- Contact ODE
FDA classification definition
A next-generation sequencing based tumor profiling test is a qualitative in vitro diagnostic test intended to detect mutations in a broad panel of targeted genes that are somatically altered in malignant neoplasms from nucleic acids isolated from human clinical specimens obtained from patients diagnosed with malignant neoplasms using targeted next-generation sequencing.
Official FDA classification page: QFK
Classification and pathway per current FDA publications. Data from openFDA (CC0).